SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-005643
Filing Date
2021-02-10
Accepted
2021-02-10 16:01:29
Documents
1
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 3472
  Complete submission text file 0000899243-21-005643.txt   4866
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02452
Business Address
Hunt Anthony (Reporting) CIK: 0001606030 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-14656 | Film No.: 21613697